Cytochrome P-450 CYP2D6 Inhibitors

DBCAT000911Therapeutic category

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2D6. A DrugBank category of 268 drugs. 235 of them are approved.

Also known as
CYP2D6 Inhibitors · CYP2D6 Inhibitors, P450 · Cytochrome P 450 CYP2D6 Inhibitors · Cytochrome P-450 CYP2D6-Inhibitors · Cytochrome P450 2D6 Inhibitor

What you can answer from here — as of September 15, 2022

268DrugsEach linked to its full drug card
Sign in
728Drug targetsEvery drug–target pair in the class, with bond type
Sign in
92,037Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
59Routes of administrationHow the drugs in this class are given
Sign in
4SubcategoriesNarrower classes within this one
Sign in

Which targets do Cytochrome P-450 CYP2D6 Inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.

Create Account